WHO validates Sinovac COVID-19 vaccine for emergency use, issues interim policy recommendations

Asha Bajaj
4 min readJun 1, 2021

#WHO; #Covid19; #SinovacCoronaVacCOVID19Vaccine; #Sage

WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies, and communities the assurance that it meets international standards for safety, efficacy, and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.

“The world desperately needs multiple COVID-19 vaccines to address the huge access

--

--

Asha Bajaj

I write on national and international Health, Politics, Business, Education, Environment, Biodiversity, Science, First Nations, Humanitarian, gender, women